|
2025
|
Invention
|
Transcriptional enhanced associate domains (teads) inhibitor compound, and pharmaceutical composi... |
|
|
Invention
|
Medicament for treating brain diseases. The present disclosure provides a medicament for treating... |
|
|
Invention
|
Trop2-targeted antibody-drug conjugate, and preparation method therefor and use thereof. Disclose... |
|
|
Invention
|
Fto inhibitors, preparation method therefor and use thereof. Provided in the present invention ar... |
|
|
Invention
|
Spiro compound, pharmaceutical composition containing same and use thereof. Disclosed in the pres... |
|
|
Invention
|
Antiviral heterocyclic scaffold derivative, preparation method therefor, pharmaceutical combinati... |
|
|
Invention
|
Quinolinium-based fap inhibitor, and preparation method therefor and use thereof. Provided in the... |
|
|
Invention
|
Use of bougainvillea glabra triterpenoid saponin compound. Provided is use of a Bougainvillea gla... |
|
2024
|
Invention
|
Squaric acid compound, pharmaceutically acceptable salt or deuterated compound thereof, preparati... |
|
|
Invention
|
Use of 1-(3-aminopropyl) substituted cyclic amine compound. The present invention relates to phar... |
|
|
Invention
|
Molecular image probe targeting poly adp ribose polymerase, and preparation method and use theref... |
|
|
Invention
|
Mitochondria-targeting probe, preparation method therefor, and application thereof. A mitochondri... |
|
|
Invention
|
Use of chemokine receptor 2 antagonist in preparation of treatment of anxiety disorders associate... |
|
|
Invention
|
Purine compound and use thereof. Provided are a purine compound and the use thereof. The purine c... |
|
|
Invention
|
Pyrazolotriazine and pyrazolopyrimidine derivatives, preparation method therefor, pharmaceutical ... |
|
|
Invention
|
Endoglycosidase s2 mutant, preparation method therefor and use thereof in antibody glycosylation ... |
|
|
Invention
|
Disaccharide-acylhydrazone or disaccharide-hydrazide linker, glyco-engineered antibody and sugar-... |
|
|
Invention
|
Pharmaceutical composition containing heteroaryl oxynaphthalene compound, preparation method ther... |
|
|
Invention
|
Heterocyclic-substituted indazolone compounds, preparation method therefor, pharmaceutical compos... |
|
|
Invention
|
Indazolone compound, preparation method therefor, pharmaceutical composition, and use. Disclosed ... |
|
|
Invention
|
Cyclic 2-aminopyrimidine compound and pharmaceutical composition and use thereof. Provided are a ... |
|
|
Invention
|
Preparation and use of fluorescent probe targeting gpr84 receptor. Disclosed in the present inven... |
|
|
Invention
|
Preparation method for spirocyclic tetrahydro-γ-carboline derivative, and use of spirocyclic tetr... |
|
|
Invention
|
N2-3-fluoro-5-substituted phenyl-2-aminopyrimidine derivative, preparation method therefor and ph... |
|
|
Invention
|
Irak4 degrader and pharmaceutical composition and pharmaceutical use thereof. The present inventi... |
|
|
Invention
|
Azetidine compound and medical use thereof. The present invention relates to an azetidine compoun... |
|
|
Invention
|
Fap-targeting compound, and radionuclide-labeled complex based thereon, and preparation method th... |
|
|
Invention
|
Protein degradation agent, and pharmaceutical composition and use thereof. A protein degradation ... |
|
|
Invention
|
Gastrodiae rhizoma oligosaccharide compound, and preparation method therefor and use thereof. The... |
|
|
Invention
|
Fap inhibitor, fap-targeted nuclide probe. and application thereof. The present invention relates... |
|
|
Invention
|
Phosphodiesterase-4 inhibitor, pharmaceutical composition comprising same, and use thereof. The p... |
|
2023
|
Invention
|
Use of targeted inhibition of p300/cbp in treating liver injury diseases. Use of targeted inhibit... |
|
|
Invention
|
.alpha., .beta.-unsaturated amide compound, and preparation method therefor, and pharmaceutical c... |
|
|
Invention
|
Isoquinolinone compound, and preparation method and use therefor.
Provided are an isoquinolinone... |
|
|
Invention
|
Preparation and anti-tumor application of gene therapy vector interfering cklf-like marvel transm... |
|
|
Invention
|
Salt of substituted amino six-membered nitric heterocyclic compound, crystal form thereof, method... |
|
|
Invention
|
Anti-human pd-ll and tlr7 double-targeting nanobody conjugate drug and use thereof in resisting t... |
|
|
Invention
|
Epa-ee lipid nanocomposite, formulation thereof, preparation method therefor, and application the... |
|
|
Invention
|
Cyclic(alkyl)(amino)alkoxy-substituted aryl-pyrone compound and use thereof.
A novel compound re... |
|
|
Invention
|
High-selectivity kcnq4 potassium channel agonist, preparation method therefor and use thereof.
D... |
|
|
Invention
|
Steroid compound, and preparation method therefor and use thereof.
Disclosed in the present inve... |
|
2022
|
Invention
|
Class of quinoline compounds, preparation method therefor, pharmaceutical composition and use the... |
|
|
Invention
|
Somatostatin receptor subtype 5 antagonists, and pharmaceutical composition and use thereof.
Pro... |
|
|
Invention
|
Aromatic heterocyclic compound and application thereof.
Disclosed are an aromatic heterocyclic c... |
|
|
Invention
|
Cyano compound, and preparation method therefor and use thereof.
The present invention provides ... |
|
|
Invention
|
Long-chain compound that acts on acly, preparation method therefor and use thereof.
A long-chain... |
|
|
Invention
|
Sulfonylurea compound, preparation method therefor, and application thereof.
The present inventi... |
|
|
Invention
|
Application of novel coronavirus vaccine peptide and nanoemulsion preparation thereof in preventi... |
|
|
Invention
|
Lignan derivative, preparation method therefor and use thereof.
Disclosed in the present inventi... |
